What to Do about Drug Shortages
Short Supply Prescription Drugs: Shining a Light on the Gray Market
July 25, 2012
Mr. Chairman and members of the committee, I am Devon Herrick, senior fellow at the National Center for Policy Analysis, a nonprofit, nonpartisan public policy research organization dedicated to developing and promoting private alternatives to government regulation and control, solving problems by relying on the strength of the competitive, entrepreneurial private sector. I appreciate the opportunity to submit this written statement for the record.
American hospitals and physicians are facing an unprecedented shortage of commonly used drugs. President Obama announced his support for legislation to address this problem by requiring drug makers to notify the Food and Drug Administration (FDA) of possible shortages six months in advance.